Aldeyra Therapeutics, Inc. ALDX
$2.27
-6.58%
at last close
Market Cap$136.93 million
P/E Ratio—
Div Yield—
Volume2.12M
52-Week Range
$1.07$6.17
Key Stats
- Today's Range
- $2.25 – $2.53
- 50-Day Range
- $1.47 – $2.53
- 52-Week Range
- $1.07 – $6.17
- Volume
- 2.12 million shs
- Average Volume
- 1.57 million shs
- Market Cap
- $136.93 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 3.25
- Price / Sales
- —
Short Interest
- Short Interest
- 0.45%
- Days to Cover
- 3.99
About Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
Related Stocks
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.